MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1371/journal.pone.0193491

Медицинская библиотека · PloS one · 2018

Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study.

Bastard Mathieu, Sanchez-Padilla Elisabeth, du Cros Philipp, Khamraev Atadjan Karimovich, Parpieva Nargiza, Tillyashaykov Mirzagaleg, Hayrapetyan Armen, Kimenye Kamene, Khurkhumal Shazina, Dlamini Themba, Perez Santiago Fadul, Telnov Alex, Hewison Cathy, Varaine Francis, Bonnet Maryline

Сравнительное исследованиеСтатьяМногоцентровое исследованиеПеревод требует повторной обработки

Аннотация

BACKGROUND

The emergence of resistance to anti-tuberculosis (DR-TB) drugs and the HIV epidemic represent a serious threat for reducing the global burden of TB. Although data on HIV-negative DR-TB treatment outcomes are well published, few data on DR-TB outcomes among HIV co-infected people is available despite the great public health importance.

METHODS

We retrospectively reported and compared the DR-TB treatment outcomes of HIV-positive and HIV-negative patients treated with an individualized regimen based on WHO guidelines in seven countries: Abkhazia, Armenia, Colombia, Kenya, Kyrgyzstan, Swaziland and Uzbekistan.

RESULTS

Of the 1,369 patients started DRTB treatment, 809 (59.1%) were multi-drug resistant (MDR-TB) and 418 (30.5%) were HIV-positive. HIV-positive patients were mainly from African countries (90.1%) while HIV-negative originated from Former Soviet Union (FSU) countries. Despite a higher case fatality rate (19.0% vs 9.4%), HIV-positive MDR-TB patients had a 10% higher success rate than HIV-negative patients (64.0% vs 53.2%, p = 0.007). No difference in treatment success was found among polydrug-resistant (PDR-TB) patients. Overall, lost to follow-up rate was much higher among HIV-negative (22.0% vs. 8.4%). Older age and not receiving ART were the only factors associated with unfavorable treatment outcome among HIV-positive patients.

CONCLUSIONS

As already known for HIV-negative patients, success rate of DR-TB HIV-positive patients remains low and requires more effective DR-TB regimen using new drugs also suitable to HIV-infected patients on ART. The study also confirms the need of ART introduction in HIV co-infected patients.

Для цитирования: Bastard Mathieu, Sanchez-Padilla Elisabeth, du Cros Philipp, Khamraev Atadjan Karimovich, Parpieva Nargiza, Tillyashaykov Mirzagaleg, Hayrapetyan Armen, Kimenye Kamene, Khurkhumal Shazina, Dlamini Themba, Perez Santiago Fadul, Telnov Alex, Hewison Cathy, Varaine Francis, Bonnet Maryline. Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study.. PloS one. 2018. DOI: 10.1371/journal.pone.0193491.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.